Ó. Jorba

发表

Efficacy of atorvastatin and gemfibrozil, alone and in low dose combination, in the treatment of diabetic dyslipidemia.

A. Wägner, J. Ordóñez‐Llanos, Antonio Pérez, 2003, The Journal of clinical endocrinology and metabolism.

Electronegative low‐density lipoprotein subfraction from type 2 diabetic subjects is proatherogenic and unrelated to glycemic control

M. Rigla, J. Ordóñez‐Llanos, R. Arcelús, 2007, Diabetes/metabolism research and reviews.

Effect of physical exercise on lipoprotein(a) and low-density lipoprotein modifications in type 1 and type 2 diabetic patients.

A. de Leiva, M. Rigla, A. Caixàs, 2000, Metabolism: clinical and experimental.

Postprandial lipidemia in normolipidemic type 2 diabetes : searching for markers

M. Rigla, A. Pérez, F. Blanco-Vaca, 2001 .

Novel phospholipolytic activities associated with electronegative low-density lipoprotein are involved in increased self-aggregation.

J. Ordóñez‐Llanos, S. Villegas, Cristina Bancells, 2008, Biochemistry.

Impaired binding affinity of electronegative low-density lipoprotein (LDL) to the LDL receptor is related to nonesterified fatty acids and lysophosphatidylcholine content.

V. Villegas, J. Ordóñez‐Llanos, F. González-Sastre, 2004, Biochemistry.

Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids.

J. Ordóñez‐Llanos, R. Arcelús, F. Blanco-Vaca, 2002, Atherosclerosis.

Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia.

J. Ordóñez‐Llanos, F. González-Sastre, F. Blanco-Vaca, 1999, The American journal of cardiology.

Platelet‐Activating Factor Acetylhydrolase Is Mainly Associated With Electronegative Low‐Density Lipoprotein Subfraction

J. Ordóñez‐Llanos, F. González-Sastre, F. Blanco-Vaca, 2003, Circulation.

Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes.

A. Wägner, J. Ordóñez‐Llanos, A. Pérez, 2004, Metabolism: clinical and experimental.

LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes

M. Rigla, J. Ordóñez‐Llanos, A. Pérez, 2002, Acta Diabetologica.

Effect of improving glycemic control on low-density lipoprotein particle size in type 2 diabetes.

A. de Leiva, M. Rigla, A. Wägner, 2003, Metabolism: clinical and experimental.

Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretion.

A. Wägner, J. Ordóñez‐Llanos, R. Arcelús, 2003, Metabolism: clinical and experimental.

Ascorbic acid inhibits the increase in low‐density lipoprotein (LDL) susceptibility to oxidation and the proportion of electronegative LDL induced by intense aerobic exercise

J. Ordóñez‐Llanos, A. Payés, F. González-Sastre, 1998, Coronary artery disease.